Townson Sharon
SEC insider (Form 3/4/5 filer). CIK 0001855689. Chief Scientific Officer at Monte Rosa Therapeutics, Inc. (GLUE). 12 reported Form 4/5 transactions since Sep 2024; latest on Jul 6, 2026. Located in BOSTON, MA.
Companies Townson Sharon has filed insider reports for
- Monte Rosa Therapeutics, Inc. (GLUE): Officer, Chief Scientific Officer
Townson Sharon
CIK: 0001855689
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Monte Rosa Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jul 6, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect400 shares at avg. $24.13$10K - Jul 6, 2026GLUE
Monte Rosa Therapeutics, Inc.
ExerciseDirect6K shares at avg. $6.14$37K - Jul 6, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect5.6K shares at avg. $23.25$130K - Jun 23, 2026GLUE
Monte Rosa Therapeutics, Inc.
ExerciseDirect3K shares at avg. $6.14$18K - Jun 23, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect3K shares at avg. $20.00$60K - Jun 17, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect3K shares at avg. $19.00$57K - Jun 17, 2026GLUE
Monte Rosa Therapeutics, Inc.
ExerciseDirect3K shares at avg. $6.14$18K - May 29, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect6K shares at avg. $19.87$119K - May 29, 2026GLUE
Monte Rosa Therapeutics, Inc.
ExerciseDirect6K shares at avg. $6.14$37K - Jan 5, 2026GLUE
Monte Rosa Therapeutics, Inc.
SaleDirect3.2K shares at avg. $15.17$48K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 6, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 400 | $24.13 | $9,652 | Direct |
| Jul 6, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Exercise | 6,000 | $6.14 | $36,840 | Direct |
| Jul 6, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 5,600 | $23.25 | $130,197 | Direct |
| Jun 23, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Exercise | 3,000 | $6.14 | $18,420 | Direct |
| Jun 23, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 3,000 | $20.00 | $60,000 | Direct |
| Jun 17, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 3,000 | $19.00 | $57,000 | Direct |
| Jun 17, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Exercise | 3,000 | $6.14 | $18,420 | Direct |
| May 29, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 6,000 | $19.87 | $119,220 | Direct |
| May 29, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Exercise | 6,000 | $6.14 | $36,840 | Direct |
| Jan 5, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Sale | 3,155 | $15.17 | $47,861 | Direct |
1-10 of 12 transactions